Bulletin Updates
Merck to acquire Spring Works, boost rare tumor portfolio – 28 Apr 2025
Apr 28, 2025
Merck moves to expand its healthcare footprint with SpringWorks buyout
The deal strengthens rare disease focus and accelerates US growth strategy
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »